JP Morgan Maintains Neutral on ArcBest, Raises Price Target to $164
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $158 to $164.
JP Morgan analyst Brian Ossenbeck maintains ArcBest (NASDAQ:ARCB) with a Neutral and raises the price target from $158 to $164.